Lv3
254 积分 2024-08-07 加入
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2′-Deoxynucleoside 5′-Monophosphate Glycosidase (DNPH1)
2天前
已完结
Discovery and Characterization of Diverse Non-nucleotide Inhibitors of DNPH1 Using an Integrated Hit Finding Strategy
2天前
已完结
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
12天前
已完结
Beyond PARP—POLθ as an anticancer target
12天前
已完结
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
20天前
已完结
Emerging Strategies to Inhibit the G1/S Transition for Cancer Therapy
1个月前
已完结
On the relationship between hERG inhibition and the magnitude of QTc prolongation: An in vitro to clinical translational analysis
1个月前
已完结
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer
1个月前
已完结
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
1个月前
已关闭
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
1个月前
已完结
皖公网安备34019202002308
